Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Small Business World Journal.

TILT Holdings Reports Second Quarter 2025 Results
SCOTTSDALE, Ariz., Aug. 14, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCID: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing,...

XWELL Reports Second Quarter 2025 Results
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing...

authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the second quarter...

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights
– Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial– – Successful completion of two large randomized...

Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial Hazard ratios and improvements in median progression-free survival (“PFS”) are...

Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Tanruprubart (formerly ANX005) for GBS Advancing Through Regulatory Interactions; MAA Submission in Europe Anticipated in First Quarter of 2026; Ongoing Discussions with FDA Regarding Generalizability Package to Support a BLA Accelerated...

Jefferson Capital Reports Second Quarter 2025 Results
47% Growth in Revenue to $152.7 Million Collections Grow 85% to $255.7 Million with Estimated Remaining Collections (“ERC”) up 31% to a Record $2.9 Billion Pre-tax Income up 82% to $62.0 Million with Net Income up 48% to $47.7 Million Adjusted...

TOMI Environmental Solutions, Inc. Reports Q2 2025 Financial Results and Outlines Growth Initiatives
FREDERICK, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today...

Birchtech Reports Second Quarter 2025 Financial Results
Second Quarter 2025 Revenues Totaled $3.3 Million, Driven by Continued Industry Recognition of Intellectual Property Portfolio CORSICANA, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) ("Birchtech" or the...

Nova LifeStyle, Inc. Reports Second Quarter FY 2025 Results
LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the second quarter ended June 30, 2025. Key Financial Highlights: Operating Results...

CapsoVision Reports Second Quarter 2025 Financial Results
SARATOGA, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its...

Innventure Reports Second Quarter 2025 Results
Accelsius significantly grew market presence with recent deployments at Global Switch, Compucenter and Equinix facilities AeroFlexx delivered a fourth consecutive quarter of revenue generation Refinity engaged an engineering, procurement and...

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of focusing on our base of routine users...

KULR Technology Group Reports Second Quarter 2025 Financial Results
HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin-Plus Treasury company that builds a portfolio of frontier technology businesses ranging from high performance energy...

Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Announced CNSide® CSF assay platform launch timeline Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the...

Duos Technologies Group Reports Second Quarter 2025 Results
JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions and operational services for the...

Super League Reports Second Quarter 2025 Financial Results
~ Q2 Gross Margin Expansion, Cost Reductions, Strategic Transactions, and Diversified Revenue Initiatives Could Position Super League to Achieve Adjusted EBITDA Positive in Q4 ~ ~ Company Advances Key Financial Initiatives and Broadens Revenue Mix...

Carryout Supplies Holds Prices Steady as Small Businesses Face Rising Tariffs
Custom packaging provider absorbs increased costs to help customers stay competitive during economic uncertainty. WALNUT, CA, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- Carryout Supplies (carryoutsupplies.com), a nationwide provider of...

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company...

Cemtrex Reports Results for Third Quarter Fiscal 2025
Hauppauge, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cemtrex Inc. (Nasdaq: CETX, CETXP), a multi-industry technology company focused on security and industrial services, today announced its financial results for the third quarter and nine months ended...